A multi-center, randomized, double-blind, placebo-controlled, five-arm parallel-group trial to investigate the efficacy and safety of four different transdermal doses of rotigotine in subjects with idiopathic restless legs syndrome.

Trial Profile

A multi-center, randomized, double-blind, placebo-controlled, five-arm parallel-group trial to investigate the efficacy and safety of four different transdermal doses of rotigotine in subjects with idiopathic restless legs syndrome.

Completed
Phase of Trial: Phase III

Latest Information Update: 30 Oct 2014

At a glance

  • Drugs Rotigotine (Primary)
  • Indications Restless legs syndrome
  • Focus Adverse reactions; Registrational
  • Sponsors UCB
  • Most Recent Events

    • 13 Jul 2010 Results published in Movement Disorders.
    • 22 Jun 2008 Results were published in the proceedings of the 12th International Congress of Parkinson's Disease and Movement Disorders, 22 Jun 2008.
    • 13 Dec 2007 Data from this study and another (700014507) used for filing Supplemental NDA (9083504).
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top